Pelorus Jack Capital, L.P. - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.

Quarter-by-quarter ownership
Pelorus Jack Capital, L.P. ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q1 2018$13,631,000
-54.4%
856,200
-40.5%
0.94%
-76.5%
Q4 2017$29,886,0001,438,2004.01%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q2 2018
NameSharesValueWeighting ↓
Bruce & Co., Inc. 850,000$6,987,0002.38%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders